Medicinova Stock Probability of Future Stock Price Finishing Over 16.5

MNOV Stock  USD 1.34  0.01  0.75%   
MediciNova's implied volatility is one of the determining factors in the pricing options written on MediciNova. Implied volatility approximates the future value of MediciNova based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in MediciNova over a specific time period. For example, 2024-06-21 CALL at $2.5 is a CALL option contract on MediciNova's common stock with a strick price of 2.5 expiring on 2024-06-21. The contract was last traded on 2024-06-07 at 09:32:19 for $0.05 and, as of today, has 10 days remaining before the expiration. The option is currently trading at a bid price of $0.0, and an ask price of $0.1. The implied volatility as of the 12th of June 2024 is 263.6. View All MediciNova options

Closest to current price MediciNova long CALL Option Payoff at Expiration

MediciNova's future price is the expected price of MediciNova instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of MediciNova performance during a given time horizon utilizing its historical volatility. Check out MediciNova Backtesting, MediciNova Valuation, MediciNova Correlation, MediciNova Hype Analysis, MediciNova Volatility, MediciNova History as well as MediciNova Performance.
For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.
  
At this time, MediciNova's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to climb to 1.63 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (10.40) in 2024. Please specify MediciNova's target price for which you would like MediciNova odds to be computed.

MediciNova Target Price Odds to finish over 16.5

The tendency of MediciNova Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 16.50  or more in 90 days
 1.34 90 days 16.50 
close to zero percent
Based on a normal probability distribution, the odds of MediciNova to move over $ 16.50  or more in 90 days from now is close to zero percent (This MediciNova probability density function shows the probability of MediciNova Stock to fall within a particular range of prices over 90 days) . Probability of MediciNova price to stay between its current price of $ 1.34  and $ 16.50  at the end of the 90-day period is about 78.88 .
Given the investment horizon of 90 days MediciNova has a beta of 1.0. This indicates MediciNova market returns are correlated to returns on the market. As the market goes up or down, MediciNova is expected to follow. Additionally MediciNova has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   MediciNova Price Density   
       Price  

Predictive Modules for MediciNova

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MediciNova. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of MediciNova's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.071.344.45
Details
Intrinsic
Valuation
LowRealHigh
1.215.148.25
Details
Naive
Forecast
LowNextHigh
0.031.304.41
Details
1 Analysts
Consensus
LowTargetHigh
15.0216.5018.32
Details

MediciNova Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. MediciNova is not an exception. The market had few large corrections towards the MediciNova's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MediciNova, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MediciNova within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.03
β
Beta against NYSE Composite1.00
σ
Overall volatility
0.07
Ir
Information ratio -0.0083

MediciNova Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MediciNova for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MediciNova can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
MediciNova may become a speculative penny stock
MediciNova had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 1000 K. Net Loss for the year was (8.57 M) with profit before overhead, payroll, taxes, and interest of 4.04 M.
MediciNova currently holds about 65.23 M in cash with (7.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.
MediciNova has a poor financial position based on the latest SEC disclosures
Latest headline from globenewswire.com: MediciNova Receives Notice of Allowance forNew Patent Covering MN-166 for the Prevention of Metastasis of Various Solid Cancer

MediciNova Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MediciNova Stock often depends not only on the future outlook of the current and potential MediciNova's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MediciNova's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding49 M
Cash And Short Term Investments51 M

MediciNova Technical Analysis

MediciNova's future price can be derived by breaking down and analyzing its technical indicators over time. MediciNova Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MediciNova. In general, you should focus on analyzing MediciNova Stock price patterns and their correlations with different microeconomic environments and drivers.

MediciNova Predictive Forecast Models

MediciNova's time-series forecasting models is one of many MediciNova's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MediciNova's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about MediciNova

Checking the ongoing alerts about MediciNova for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MediciNova help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
MediciNova may become a speculative penny stock
MediciNova had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 1000 K. Net Loss for the year was (8.57 M) with profit before overhead, payroll, taxes, and interest of 4.04 M.
MediciNova currently holds about 65.23 M in cash with (7.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.
MediciNova has a poor financial position based on the latest SEC disclosures
Latest headline from globenewswire.com: MediciNova Receives Notice of Allowance forNew Patent Covering MN-166 for the Prevention of Metastasis of Various Solid Cancer

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.